8-K Announcements
6Material company update
Feb 11, 2026·SEC
Material company update
Dec 17, 2025·SEC
Material company update
Dec 10, 2025·SEC
STRATA Skin Sciences faces a challenging transition as it attempts to scale the TheraClear X platform amidst a shrinking asset base and persistent operational losses.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Benchmark SSKN against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for STRATA Skin Sciences, Inc. (SSKN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.00 | $589 | -0.00 | -8.54% | -21.13% | -360.33% | — | |
| $4.47 | $123.02M | -20.14 | 10.2% | -8.95% | -20.23% | — | |
| $15.71 | $102.23M | -5.60 | -10.02% | -6.33% | -32.11% | — | |
| $100.61 | $6.55B | 25.50 | 0.5% | 17.28% | 21.72% | — | |
| $13.33 | $766.22M | 10.21 | -6.16% | 20.69% | 11.8% | — | |
| $12.37 | $154.54M | -52.77 | 14.52% | -7.12% | -74.71% | — |
STRATA Skin Sciences, Inc. (SSKN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
STRATA Skin Sciences, Inc. (SSKN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Feb 11, 2026·SEC
Dec 17, 2025·SEC
Dec 10, 2025·SEC
Get notified when SSKN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STRATA Skin Sciences, Inc. (SSKN) stock FAQ — growth, dividends, profitability & financials explained
STRATA Skin Sciences, Inc. (SSKN) reported $30.7M in revenue in fiscal year 2025, which is also its trailing twelve months.
STRATA Skin Sciences, Inc. (SSKN) revenue fell by 8.5% over the trailing twelve months, compared with the twelve months before.
No. STRATA Skin Sciences, Inc. (SSKN) reported a net loss of $6.5M over the trailing twelve months.
STRATA Skin Sciences, Inc. (SSKN) had a return on equity (ROE) of -360.3% over the trailing twelve months. A negative ROE means the company lost money over the period.
STRATA Skin Sciences, Inc. (SSKN) had negative free cash flow of $4.3M over the trailing twelve months.